A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease

Documenti analoghi

• Clinician's attitudes & perspective on chemical adherence testing in hypertension (CATCH): A qualitative interview study
  di: Roshan Shahab, et al.
  Pubblicazione: (2026)
• The persistence of chronic opioid use in patients with inflammatory bowel disease—A nationwide cohort study
  di: Bente Mertz Nørgård, et al.
  Pubblicazione: (2025)
• The prevalence of polypharmacy increases with age among patients with inflammatory bowel disease: A nationwide cohort study
  di: Ken Lund, et al.
  Pubblicazione: (2025)
• Clinical outcomes of switching to dolutegravir/lamivudine dual therapy in people living with HIV: A single‐centre retrospective study
  di: D. Yagci‐Caglayik, et al.
  Pubblicazione: (2025)
• Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis
  di: Obreniokibo Ibifubara Amiesimaka, et al.
  Pubblicazione: (2024)